Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Cerebral Therapeutics has raised $40.0M in total funding. The most recent round was Series C. The last funding was announced in June 2022.
Cerebral Therapeutics's investors include RA Capital Management, Vivo Capital, Perceptive Advisors, Lynx1 Capital Management, Granite Point Capital.
Cerebral Therapeutics is headquartered in Aurora, United States.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Cerebral Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cerebral Therapeutics — Funding & Investors." VCBacked, June 28, 2022, https://www.vcbacked.co/company/cerebral-therapeutics. Accessed July 19, 2026.
VCBacked. (2022). Cerebral Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cerebral-therapeutics
{{cite web |title=Cerebral Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cerebral-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated